Medicare Enrolled
Dr. Tricia Gilbert, MD
Pulmonary Disease · East Brunswick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gilbert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gilbert?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gilbert
Dr. Tricia Gilbert is a pulmonary disease specialist in East Brunswick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gilbert performed 2,188 Medicare services across 1,332 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gilbert received a total of $5,049 from 39 pharmaceutical and/or device companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gilbert is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 31% volume in NJ
$5,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,188
Medicare services
Top 31% in NJ for pulmonary disease
1,332
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $107 | $482 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
506 | $101 | $461 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
204 | $67 | $343 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
148 | $184 | $1,068 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $74 | $307 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
101 | $24 | $127 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
101 | $50 | $208 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
101 | $53 | $216 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $46 | $167 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $146 | $667 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
68 | $50 | $103 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
60 | $148 | $858 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
34 | $38 | $199 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
26 | $100 | $483 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
20 | $72 | $218 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $34 | $101 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,049
Total received (2018-2024)
Avg $721/year across 7 years
Top 31% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,896 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$153 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$998
2023
$989
2022
$789
2021
$392
2020
$171
2019
$955
2018
$754
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$159
GENZYME CORPORATION
$124
Mylan Specialty L.P.
$117
Amgen Inc.
$99
GlaxoSmithKline, LLC.
$98
HARMONY BIOSCIENCES LLC
$55
Regeneron Healthcare Solutions, Inc.
$49
Grifols USA, LLC
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Merck Sharp & Dohme LLC
$34
Axsome Therapeutics, Inc.
$33
Novartis Pharmaceuticals Corporation
$28
Avadel CNS Pharmaceuticals, LLC
$27
Inspire Medical Systems, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
CSL Behring
$21
SANOFI-AVENTIS U.S. LLC
$21
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$977
AstraZeneca Pharmaceuticals LP
$673
Mylan Specialty L.P.
$374
Boehringer Ingelheim Pharmaceuticals, Inc.
$364
GENZYME CORPORATION
$285
Regeneron Healthcare Solutions, Inc.
$237
Amgen Inc.
$223
Insmed, Inc.
$184
Novartis Pharmaceuticals Corporation
$160
Sunovion Pharmaceuticals Inc.
$143
Genentech USA, Inc.
$136
Harmony Biosciences LLC
$132
CSL Behring
$103
Axsome Therapeutics, Inc.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$93
Grifols USA, LLC
$90
HARMONY BIOSCIENCES LLC
$81
Boston Scientific Corporation
$69
Astellas Pharma US Inc
$62
Merck Sharp & Dohme LLC
$53
Inogen, Inc.
$47
Avadel CNS Pharmaceuticals, LLC
$45
Mallinckrodt Hospital Products Inc.
$43
Mallinckrodt Enterprises LLC
$42
E.R. Squibb & Sons, L.L.C.
$29
Janssen Pharmaceuticals, Inc
$29
PFIZER INC.
$29
Advanced Respiratory, Inc
$28
Shire North American Group Inc
$27
Teva Pharmaceuticals USA, Inc.
$26
Inspire Medical Systems, Inc.
$24
Baxter Healthcare
$23
Bayer Healthcare Pharmaceuticals Inc.
$23
SANOFI-AVENTIS U.S. LLC
$21
United Therapeutics Corporation
$18
Resmed Corp
$17
JAZZ PHARMACEUTICALS INC.
$15
Merck Sharp & Dohme Corporation
$15
SANOFI PASTEUR INC.
$13
Top 3 companies account for 40.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ARALAST · AirSense · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHANTIX · CRESEMBA · CUVITRU · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · Kerendia · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · Prolastin-C Liquid · REZUROCK · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UTIBRON NEOHALER · Utibron · WAKIX · WATCHMAN · WATCHMAN Access System · Wakix · XARELTO · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
157
Per 100K population
18.2
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gilbert is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gilbert experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gilbert performed 533 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gilbert receive payments from pharmaceutical companies?
Yes. Dr. Gilbert received a total of $5,049 from 39 companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gilbert's costs compare to other pulmonary diseases in East Brunswick?
Dr. Gilbert's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gilbert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in East Brunswick
Browse pulmonary diseases in East Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology